Cargando…
miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
Oligonucleotide-based therapies are currently gaining attention as a new treatment option for relatively rare as well as common diseases such as cardiovascular disease. With the remarkable progression of new sequencing technologies, a further step towards personalized precision medicine to target a...
Autores principales: | Huang, Cheng-Kai, Bär, Christian, Thum, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243366/ https://www.ncbi.nlm.nih.gov/pubmed/32499708 http://dx.doi.org/10.3389/fphar.2020.00726 |
Ejemplares similares
-
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022) -
Reply to ‘COVID‐19 severity, miR‐21 targets, and common human genetic variation’
por: Derda, Anselm A., et al.
Publicado: (2021) -
Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System
por: Xu, Kaizu, et al.
Publicado: (2021) -
Editorial: Cardiorenal dysregulation in endocrine disorders: innovative mechanisms and therapeutic interventions
por: Shawky, Noha M., et al.
Publicado: (2023) -
Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease
por: Goldschmidt, Imeke, et al.
Publicado: (2016)